Gout Clinical Trial

Trial Summary

Have you been diagnosed with the gout? Please contact us to learn more about this new clinical trial, as we are looking for qualified applicants who’d be interested in participating.

This clinical research study was designed to to evaluate the efficacy of two dose levels of an experimental gout medication administered once daily for the prevention of flares in adult patients with gout.

Key Inclusion Criteria

  • Open to male or female patients between 18 and 75 years of age
  • Confirmed gout diagnosis (per criteria of the American Rheumatism Association for the classification of the acute arthritis of primary gout)
  • At least three patient-reported and documented flares during the 12 months prior to screening
  • Have not used any urate lowering therapy (ULT) for at least two weeks prior to screening
  • Electrocardiogram (ECG) must be normal, or if abnormal, considered not clinically significant at screening
  • All other clinical laboratory parameters must be within normal limits or considered not clinically significant

Compensation for Time and Travel

Study related care including physical examinations, laboratory services and study medications are all provided to participants free of charge. Please feel free to contact us if you have any further questions about how you can be compensated for your participation.

Gout Signs and Symptoms

The inflammation caused by gouty arthritis can cause one or more joints to become painfully inflamed, tender and reddened. However, more than half of all diagnosed cases of gout involve the metatarsal-phalangeal joint of the big toe. Additionally, the joints in the knees, heels, wrists and fingers can also be affected the symptoms of gout. An acute case can be very painful but is usually isolated to one joint. Chronic cases of gout are much more painful with several joints affected simultaneously.

This Clinical Trial is Now Closed

At this time, we are no longer enrolling new volunteers for this gout clinical trial. We will update this page if the clinical trial is re-opened. If you have any questions about this particular study or any of our other clinical trials here in Birmingham, please give us a call at (205) 380-6434.